STOCK TITAN

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Medifast (NYSE: MED), the health and wellness company behind the OPTAVIA® lifestyle solution, has scheduled its fourth quarter and full year 2024 financial results announcement for Tuesday, February 18, 2025, after market close.

The company will host a conference call at 4:30 p.m. ET on the same day, featuring Chairman and CEO Dan Chard and CFO Jim Maloney. The call will be broadcast live on Medifast's Investor Relations website and will remain archived through May 18, 2025. Telephone participants can dial (201) 389-0879 to join, with a playback available from 8:30 p.m. ET through February 25, 2025, accessible at (412) 317-6671 with access code 13751326.

Medifast (NYSE: MED), l'azienda di salute e benessere dietro la soluzione di stile di vita OPTAVIA®, ha programmato l'annuncio dei risultati finanziari del quarto trimestre e dell'anno intero 2024 per martedì 18 febbraio 2025, dopo la chiusura del mercato.

L'azienda ospiterà una conferenza telefonica alle 16:30 ET nello stesso giorno, con la partecipazione di Chairman e CEO Dan Chard e CFO Jim Maloney. La chiamata sarà trasmessa in diretta sul sito delle relazioni con gli investitori di Medifast e rimarrà disponibile in archivio fino al 18 maggio 2025. I partecipanti telefonici possono comporre il numero (201) 389-0879 per partecipare, con una riproduzione disponibile dalle 20:30 ET fino al 25 febbraio 2025, accessibile al numero (412) 317-6671 con il codice di accesso 13751326.

Medifast (NYSE: MED), la empresa de salud y bienestar detrás de la solución de estilo de vida OPTAVIA®, ha programado el anuncio de resultados financieros del cuarto trimestre y del año completo 2024 para martes 18 de febrero de 2025, después del cierre del mercado.

La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. ET el mismo día, con la participación de Chairman y CEO Dan Chard y CFO Jim Maloney. La llamada se transmitirá en vivo en el sitio web de Relaciones con Inversores de Medifast y se mantendrá archivada hasta el 18 de mayo de 2025. Los participantes telefónicos pueden marcar el (201) 389-0879 para unirse, con una reproducción disponible desde las 8:30 p.m. ET hasta el 25 de febrero de 2025, accesible al (412) 317-6671 con el código de acceso 13751326.

메디패스트 (NYSE: MED), OPTAVIA® 라이프스타일 솔루션의 건강 및 웰빙 기업, 2024년 4분기 및 연간 재무 결과 발표를 2025년 2월 18일 화요일, 마감 후로 예정했습니다.

회사는 같은 날 오후 4시 30분 ET에 회장 겸 CEO 댄 차드CFO 짐 말로니가 참석하는 전화 회의를 주최할 것입니다. 이 전화 회의는 메디패스트의 투자자 관계 웹사이트에서 생중계되며 2025년 5월 18일까지 아카이브됩니다. 전화로 참여하려는 분은 (201) 389-0879로 전화하면 되고, 2025년 2월 25일까지 오후 8시 30분부터 재생이 가능하며, (412) 317-6671로 접속 코드 13751326과 함께 액세스할 수 있습니다.

Medifast (NYSE: MED), l'entreprise de santé et de bien-être derrière la solution de style de vie OPTAVIA®, a programmé l'annonce de ses résultats financiers pour le quatrième trimestre et l'année complète 2024 pour mardi 18 février 2025, après la fermeture du marché.

L'entreprise animera une conférence téléphonique à 16h30 ET le même jour, avec la participation de président et PDG Dan Chard et de directeur financier Jim Maloney. L'appel sera diffusé en direct sur le site Internet des relations investisseurs de Medifast et restera archivé jusqu'au 18 mai 2025. Les participants peuvent composer le (201) 389-0879 pour rejoindre l'appel, avec une lecture disponible de 20h30 ET jusqu'au 25 février 2025, accessible au (412) 317-6671 avec le code d'accès 13751326.

Medifast (NYSE: MED), das Gesundheits- und Wellnessunternehmen hinter der OPTAVIA® Lebensstiloslösung, hat die Bekanntgabe der finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 auf Dienstag, den 18. Februar 2025 nach Börsenschluss terminiert.

Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz veranstalten, an der Vorsitzender und CEO Dan Chard sowie CFO Jim Maloney teilnehmen werden. Die Konferenz wird live auf der Investor-Relations-Website von Medifast übertragen und bleibt bis zum 18. Mai 2025 archiviert. Telefoninteressierte können sich unter (201) 389-0879 einwählen, mit einem Playback, das von 20:30 Uhr ET bis zum 25. Februar 2025 verfügbar ist, zugänglich unter (412) 317-6671 mit dem Zugangscode 13751326.

Positive
  • None.
Negative
  • None.

BALTIMORE--(BUSINESS WIRE)-- Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

The conference call is scheduled to begin at 4:30 p.m. ET on February 18, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly at https://viavid.webcasts.com/starthere.jsp?ei=1705513&tp_key=7b87c842ba and will be archived online and available through May 18, 2025. To join via telephone, listeners may dial (201) 389-0879.

A telephonic playback will be available from 8:30 p.m. ET, February 18, 2025, through February 25, 2025. Participants can dial (412) 317-6671 and enter access code 13751326 to hear the playback.

About Medifast®

Medifast (NYSE: MED) is the 40+ year old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. Through the company’s collaboration with national virtual primary care provider LifeMD® (Nasdaq: LFMD) and its affiliated medical group, customers now have access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature™. Visit MedifastInc.com and OPTAVIA.com for more information and follow Medifast on X and LinkedIn.

MED-F

Investor Contact:

Medifast, Inc.

Steven Zenker

InvestorRelations@medifastinc.com

(443) 379-5256

Source: Medifast

FAQ

When will Medifast (MED) release its Q4 and full-year 2024 earnings?

Medifast will release its Q4 and full-year 2024 earnings on Tuesday, February 18, 2025, after market close.

How can investors access Medifast's (MED) Q4 2024 earnings call?

Investors can access the call by dialing (201) 389-0879 at 4:30 p.m. ET on February 18, 2025, or by visiting Medifast's Investor Relations website for the live webcast.

How long will Medifast's (MED) Q4 2024 earnings call recording be available?

The earnings call recording will be available through May 18, 2025, on Medifast's website, with telephone playback available through February 25, 2025.

What is the playback access code for Medifast's (MED) Q4 2024 earnings call?

The playback access code is 13751326, which can be used by dialing (412) 317-6671.

Medifast

NYSE:MED

MED Rankings

MED Latest News

MED Stock Data

156.74M
10.66M
2.55%
86%
12.84%
Personal Services
Miscellaneous Food Preparations & Kindred Products
Link
United States
OWINGS MILLS